Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study
about
Newer positron emission tomography radiopharmaceuticals for radiotherapy planning: an overviewValidation of functional imaging as a biomarker for radiation treatment responseImaging tumour hypoxia with positron emission tomographyImaging tumor hypoxia to advance radiation oncologyThe clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunitiesPositron emission tomography to assess hypoxia and perfusion in lung cancerReproducibility of (18)F-fluoromisonidazole intratumour distribution in non-small cell lung cancerIntroduction to the analysis of PET data in oncology.18F-Fluoromisonidazole Quantification of Hypoxia in Human Cancer Patients Using Image-Derived Blood Surrogate Tissue Reference RegionsFluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.Pharmacokinetic Analysis of Dynamic 18F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer.[18F]-Fluoromisonidazole positron emission tomography/computed tomography visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spine.Recent advances in radiotherapy.Molecular mechanisms of hypoxia in cancer.Clinical biomarkers for hypoxia targetingRadiosynthesis of [(131)I]IAZGP via nucleophilic substitution and its biological evaluation as a hypoxia marker - is specific activity a factor influencing hypoxia-mapping ability of a hypoxia marker?PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidenceNoninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases.Broadening the scope of image-guided radiotherapy (IGRT).18F-FDG PET/CT for image-guided and intensity-modulated radiotherapy.Non-invasive imaging of angiogenesis in head and neck squamous cell carcinomaFunctional and molecular image guidance in radiotherapy treatment planning optimization.The promise and pitfalls of positron emission tomography and single-photon emission computed tomography molecular imaging-guided radiation therapy.F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapyMultimodality functional imaging in radiation therapy planning: relationships between dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET.Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot sAn approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head-and-neck cancer.Increase in Tumor Control and Normal Tissue Complication Probabilities in Advanced Head-and-Neck Cancer for Dose-Escalated Intensity-Modulated Photon and Proton Therapy.Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers.PET/CT in Radiotherapy Planning for Head and Neck CancerCurrent oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer.One-stop-shop tumor imaging: buy hypoxia, get lactate free.Estimate of the impact of FDG-avidity on the dose required for head and neck radiotherapy local controlThe influence of changes in tumor hypoxia on dose-painting treatment plans based on 18F-FMISO positron emission tomography.Clinical application of intensity-modulated radiotherapy for head and neck cancer.A prospective clinical trial of tumor hypoxia imaging with 18F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy.Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer.Molecular imaging of cancer: evaluating characters of individual cancer by PET/SPECT imaging.Recent advances in image-guided radiotherapy for head and neck carcinoma.Assessing Tumor Oxygenation for Predicting Outcome in Radiation Oncology: A Review of Studies Correlating Tumor Hypoxic Status and Outcome in the Preclinical and Clinical Settings
P2860
Q26767172-167D9074-F623-4CAE-8F55-EE8F3C40D8A0Q26823165-620B3B1D-8A8B-4A8A-B32A-918A88584DDDQ26851422-AFC601BE-493C-4F2D-8292-51CBB9D73C03Q27007862-3DB8075B-5E4B-4D76-A8DC-6F9E0BF44E2EQ27025579-2634A73F-0C13-493D-817E-2621EDA5424BQ27026940-3A0880DF-AC08-4BB6-AAD0-540A3D23CCFEQ28821970-2DFA9644-C06F-4590-AE84-7B278EE1818FQ30594766-89951BC2-3391-477C-877F-D477DA5E752BQ30660095-253017F9-0620-4F3A-8555-56CEEAFA5301Q30884020-77B41974-9F4F-4BCE-A31C-5B102D0F8B41Q31165401-1B0428F8-8AA0-46F9-A6C4-BB1D76CE337CQ33275483-BABF80E0-3F2E-4275-972F-43717BAD1CF9Q33567305-F85787F0-05CB-4D86-907A-7ADD89225B2CQ33705108-3339B98A-4F09-4E7B-AF82-BF385B8CA9FDQ33714638-B3CC5837-D55E-43C5-8C4D-1C4B7C0B9D45Q33723814-40E74A17-1355-4F48-814E-ED9AACB65A44Q33818999-80378194-6D68-41D7-9B2B-0D23E7899529Q33925417-4F2DD4BA-E2AA-41BB-8F13-255CD9ECFBA0Q33943514-A61A0BF5-B16E-445E-B104-77DAC791561CQ33973367-F4904494-D162-40D8-9FF8-5E65D61895EDQ34029591-7476FFC1-7E80-45F5-B748-C070454CE682Q34706820-9C9B6E81-BF68-40EB-B441-0842F087C411Q35111985-ABA209B6-8E90-48B0-9CDF-F901085E8855Q35116993-EEB1CF9D-91EF-4100-900C-ABD007655FF4Q35151522-88768D20-CFAB-4C9D-B029-B603A399D1A9Q36153707-FF764A07-2387-4179-A978-F00F9E6BF83FQ36173661-ED8B2CE1-B199-4859-9009-7E4934F5F986Q36300626-678F23A3-9F60-4D54-860F-A21DC12A962BQ36343896-6DD2E589-F498-4465-BC82-808D170196D2Q36455944-90BBD209-478F-4AFB-934B-E744963C3CCEQ36529838-0CE37D70-983D-4DAA-A211-06808C9FB73EQ36570510-F58790BA-015E-4E57-8813-0E25BCD33802Q36770099-17A34C34-AB17-4B74-9F25-06DE16FD7AA0Q37201935-C3E647C7-B89A-47D0-9C97-B676BDD6BC66Q37217016-4C918199-31AF-493B-BB75-6650BDCBF4DDQ37297234-D5057499-0EAF-427C-8C8F-63B161BDC37AQ37333035-0191454D-B7DE-4917-A09F-001E48AADD75Q37372774-B66D3A74-D817-4D28-AFC0-CAE8CC75EBDAQ37567466-53331CFA-B299-46A4-8173-F5A4F3E616B3Q37604088-135D09B5-F7F2-41B9-BE44-85B17F469AEF
P2860
Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Fluorine-18-labeled fluoromiso ...... ck cancer: a feasibility study
@en
type
label
Fluorine-18-labeled fluoromiso ...... ck cancer: a feasibility study
@en
prefLabel
Fluorine-18-labeled fluoromiso ...... ck cancer: a feasibility study
@en
P2093
P2860
P1476
Fluorine-18-labeled fluoromiso ...... ck cancer: a feasibility study
@en
P2093
Carlo Greco
Clifton C Ling
Heiko Schöder
John L Humm
Kelvin Chan
Nancy Y Lee
Olivia D Squire
Pasquale B Zanzonico
Sadek Nehmeh
Shangde Cai
P2860
P356
10.1016/J.IJROBP.2007.06.039
P407
P577
2007-09-14T00:00:00Z